Better Biopharma

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Tyler Menichiello Episode 2

In this episode of Better Biopharma, Abalone Bio's CEO and co-founder, Richard Yu, Ph.D., explains how the company's functional antibody selection technology (FAST) platform differs from traditional affinity screening.

Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions